Infectious disease diagnostics market Size, Opportunity, and Industry Expansion Strategies to 2028

Comments · 180 Views

The infectious disease diagnostics market size is expected to reach USD 9.5 billion by 2028 registering a CAGR of 3.4% over the forecast period, according to the latest report by Reports and Data. Major factor driving market revenue growth is paradigm shift in diagnostics from centralized

The infectious disease diagnostics market size is expected to reach USD 9.5 billion by 2028 registering a CAGR of 3.4% over the forecast period, according to the latest report by Reports and Data. Major factor driving market revenue growth is paradigm shift in diagnostics from centralized labs toward practitioners’ offices.

Point-of-care tests (POCTs) are testing services performed in a hospital consultation rather than in a conventional central laboratory, using small analytical instruments to analyse blood, saliva, urine, and faeces. Studies in Europe have shown that POCTs are useful in primary care.

POC diagnostics assists users in increasing productivity, simplifying processes and procedures, complying with regulatory and performance standards, and reducing staff pressure. The primary care POC diagnostics market will be driven by a combination of primary care and efficacity POC diagnostics, which will increase the field of healthcare dramatically over the forecast period.

According to estimates, the reduced cost of waiting for results saves up to USD 260 per patient. This will help patients reduce their waiting time by up to 46 minutes per patient. Such advantages are projected to boost the demand for primary care point-of-care diagnostics.

Market Overview:

The global Primary Care POC Diagnostics market has significantly grown over the recent past and is expected to register rapid growth over the forecast period of 2021 to 2028. The pharma and healthcare sector is rapidly evolving with innovations in technology, increasing healthcare spending and improving healthcare facilities and systems. Many hospitals, ambulatory surgical care centers and clinics across the globe are adopting advanced devices and equipment. Revenue growth of the global Primary Care POC Diagnostics market is significantly driven by factors such as increasing prevalence of chronic diseases, rapid advancements in healthcare and medical sector, high adoption of latest tools and techniques and growing funds by several public and private sectors. In addition, rising focus on drug development, increasing demand for precision medicine, high adoption of home care settings and point-of-care diagnostics, increasing investments in research and development activities are expected to drive global market revenue growth during the forecast period.

Top Companies Profiled in the Report:

Roche Diagnostics, BD Biosciences, Danaher Corporation, Abbott Laboratories, Instrumentation Laboratory, bioMerieux, Siemens Healthcare, and Quidel Corporation.

Competitive Landscape:

The global market comprises various market players operating at regional and global levels. These key players are adopting various strategies such as RD investments, license agreements, partnerships, merger and acquisitions, collaborations, and joint ventures to gain robust footing in the market.

Primary Care POC Diagnostics Market Segmentation:

Product Outlook (Revenue, USD Billion; 2018 – 2028)

  • Glucose Testing
  • Hb1Ac Testing
  • Coagulation
  • Fertility
  • Infectious Diseases
  • Cardiac Markers
  • Thyroid Stimulating Hormone
  • Haematology
  • Primary Care Systems
  • Decentralized Clinical Chemistry
  • Faeces
  • Lipid Testing
  • Cancer Marker
  • Blood Gas/Electrolytes
  • Ambulatory Chemistry
  • Drug Abuse Testing
  • Urinalysis

By End Use Outlook (Revenue, USD Billion; 2018 – 2028)

  • Pharmacy Retail Clinics
  • Physician Office
  • Urgent Care Clinics
  • Non-practice Clinics

Regional Outlook of the Global Primary Care POC Diagnostics Market

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • India
    • China
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Peru
    • Mexico
    • Rest of Latin America
  • Middle East Africa
    • Saudi Arabia
    • South Africa
    • U.A.E
    • Rest of Middle East Africa

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/4097

Thank you for reading the research report on global Primary Care POC Diagnostics market. Kindly contact us to know more about the customization feature and our team will offer the best suited report as per your requirement.

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Comments